Paradigm Biopharmaceuticals Ltd.

The current price of PBIGF is 0.1900 USD — it has increased by 5.97% in the past 24 hours. Watch Paradigm Biopharmaceuticals Ltd. stock price performance more closely on the chart.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Paradigm Biopharmaceuticals Ltd. stocks are traded under the ticker PBIGF.

Paradigm Biopharmaceuticals Ltd. is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.

PBIGF stock is 5.63% volatile and has beta coefficient of 0.21. Track Paradigm Biopharmaceuticals Ltd. stock price on the chart and check out the list of the most volatile stocks — is Paradigm Biopharmaceuticals Ltd. there?

Yes, you can track Paradigm Biopharmaceuticals Ltd. financials in yearly and quarterly reports right on TradingView.

PBIGF stock has risen by 1.82% compared to the previous week, the month change is a 14.18% fall, over the last year Paradigm Biopharmaceuticals Ltd. has showed a 71.41% decrease.

Today Paradigm Biopharmaceuticals Ltd. has the market capitalization of ‪54.53 M‬, it has decreased by 0.10% over the last week.

No, PBIGF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, PBIGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Paradigm Biopharmaceuticals Ltd. stock right from TradingView charts — choose your broker and connect to your account.

PBIGF reached its all-time high on Feb 4, 2020 with the price of 3.0000 USD, and its all-time low was 0.1669 USD and was reached on Apr 11, 2024. View more price dynamics on PBIGF chart.
See other stocks reaching their highest and lowest prices.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Paradigm Biopharmaceuticals Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Paradigm Biopharmaceuticals Ltd. stock shows the sell signal. See more of Paradigm Biopharmaceuticals Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.